Results for tag: "Biliary Cancer Drug"

Biliary cancer is a type of cancer that affects the bile ducts, which are responsible for carrying bile from the liver to the small intestine. Treatment for biliary cancer typically involves a combination of chemotherapy, radiation therapy, and surgery. Oncology drugs are used to treat biliary cancer, and the biliary cancer drug market is a subset of the larger oncology drug market. Biliary cancer drugs are typically used to reduce the size of tumors, reduce symptoms, and improve the patient's quality of life. Commonly used biliary cancer drugs include gemcitabine, capecitabine, and oxaliplatin. These drugs are used in combination with other treatments, such as radiation therapy and surgery, to improve the patient's prognosis. The biliary cancer drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are constantly developing new drugs and treatments to improve the outcomes of biliary cancer patients. Show Less Read more